思力华能倍乐价格多少钱
It is a classic drug for the treatment of stable COPD. On this basis, Boehringer Ingelheim has specially developed a new inhaled long-acting β2 receptor agonist olodaterol.
At the "New Era of COPD Treatment" conference held in Guangzhou recently, experts such as Zhong Nanshan introduced the current status of COPD treatment and the status of drugs. At present, the main drugs used to treat COPD in China are bronchodilators and inhaled corticosteroids. Regarding the options for these two treatments, Academician Zhong Nanshan said at the meeting that for early-stage patients with mild symptoms, the widespread use of inhaled corticosteroids (ICS) is not a better option.
In the treatment of COPD, bronchodilators are superior to ICS, whether as single agents or in combination. At present, bronchodilators have become the core drugs in the treatment of stable COPD. Academician Zhong Nanshan also pointed out that early diagnosis and early treatment, rational application of ICS, and early use of bronchodilators are the future development trends of standardized treatment of COPD in China.
Slivar Respimat (tiotropium bromide/olodaterol inhalation spray) is a new drug developed by Boehringer Ingelheim. It has been officially approved by the China Food and Drug Administration and is suitable for long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD, referred to as COPD, including chronic bronchitis and emphysema) to relieve symptoms.
A large amount of clinical research data proves that Spirava Respimat can provide patients with COPD with better effects than Spirava®, including controlling COPD symptoms, reducing the risk of acute exacerbations, and improving patients' quality of life, and its safety is equivalent to that of Spirava®. More studies have proven that dual-branch expanders can reduce the risk of acute exacerbations compared with ICS/LABA; and unlike other dual-branch expanders, Spirava Respimat is better than Spirava in preventing acute exacerbations.
Currently, it can be purchased in China. For specific prices and related questions, please contact Medical Companion Travel, and we will provide you with sincere answers.
Recommended related hot articles: /newsDetail/82298.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)